P. Subramaniam et al., P53 TUMOR-SUPPRESSOR GENE-EXPRESSION IN HYPERPARATHYROIDISM, Australian and New Zealand journal of surgery, 66(5), 1996, pp. 302-304
Background: Mutations of the p53 tumour suppressor gene lead to the lo
ss of control of normal cellular proliferation and differentiation and
have been shown to be associated with the development of malignancy.
Method: Archival paraffin resection specimens from 86 cases of hyperpa
rathyroidism treated surgically using the rabbit poly clonal CMI antib
ody were investigated to detect p53 immunoreactivity in these sections
. Results: Eighteen of the 86 sections examined (21%) showed nuclear i
mmunoreactivity. No correlation was detected between tumour histology
and p53 immunoreactivity (P = 0.45), nor was there any correlation bet
ween tumour clonality and immunoreactivity (P = 0.54). Multiple endocr
ine neoplasia type 1 (MEN 1) status did not correlate with p53 immunor
eactivity, A significant correlation between p53 immunoreactivity and
preparathyroidectomy calcium levels of > 1.5 mmol/L was detected (P <
0.005) although no correlation was noted between p53 immunoreactivity
and higher levels of preparathyroidectomy intact parathyroid hormone (
PTH) levels. Conclusion: A relationship is postulated between abnormal
serum calcium regulation and p53 mutation in hypercalcaemic stales as
sociated with hyperparathyroidism.